Top

Published in:

01-12-2015 | Original Article

Benign Prostatic Hyperplasia Treatment by Transurethral Enucleation of the Prostate Using a 2-μm Laser

Authors: He-Qing Guo, Gao-Biao Zhou, Hong-Ming Liu, Bin Sun, Guang-Xin Pan, Da-Wei Mu, Jing-Ming Yan, Ji-Zhang Xing, Di Li, Quan Hong

Published in: Indian Journal of Surgery | Special Issue 3/2015

Abstract

This study investigates the efficacy of benign prostatic hyperplasia (BPH) treatment by prostate transurethral enucleation using a 2-μm laser. A total of 107 patients with BPH were treated by prostate transurethral enucleation using a RevoLix 2-μm laser surgery system. Bleeding volume, operation time, catheterization time, voiding situation, maximum urinary flow rate, and hospital stay were observed. The mean operation time was 74 min ± 12 min (range 45 to 150 min), the mean follow-up period was 2 to 6 months, the mean catheter time was 5 days, and the mean peak urinary flow rate increased from 6.3 ± 0.6 to 17.5 ± 1.5 mL/s. The International Prostate Symptom Score and quality of life significantly declined (p < 0.01). No significant differences were observed in the hemoglobin and blood electrolytes before and after operation. Prostate transurethral enucleation using a 2-μm laser is safe and efficient for BPH treatment.

Uchida T, Ohori M, Soh S, Sato T, Iwamura M, Ao T, Koshiba K (1999) Factors influencing morbidity in patients undergoing transurethral resection of the prostate. Urology 53:98–105CrossRefPubMed

AUA Practice Guidelines committee (2003) AUA guideline on management of benign prostatic hyperplasia. Chapter 1: diagnosis and treatment recommendations. J Urol 170:530–547CrossRef

Hammadeh MY, Madaan S, Singh M, Philp T (2000) A 3-year follow-up of a prospective randomized trial comparing transurethral electrovaporization of the prostate with standard transurethral prostatectomy. BJU Int 86:648–651CrossRefPubMed

Mattioli S, Mnuoz R, Racasens R, Berbegal C, Cortada J, Urmeneta JM, Teichmann H (2008) Treatment of benign prostatic hyperplasia with the Revolix laser. J Arch Esp Urol 61:1037–1043

Fitzpatrick JM, Mebust KW (2004) Minimally invasive and endoscopic management of benign prostatic hyperplasia. In: Walsh CW, Retik AB, Vaughan ED, Wein AJ (eds) Campbell’s urology, 8th edn. WB Saunders, Philadelphia, p 1402

Westenberg A, Gilling P, Kennett K, Frampton C, Fraundorfer M (2004) Holmium laser resection of the prostate versus transurethral resection of the prostate: results of a randomized trial with 4-year minimum long-term followup. J Urol 172:616–619CrossRefPubMed

Shingleton WB, Farabaugh P, May W (2002) Three-year follow-up of laser prostatectomy versus transurethral resection of the prostate in men with benign prostatic hyperplasia. Urology 60:305–308CrossRefPubMed

Chen CH, Chiang PH, Lee WC, Chuang YC, Kang CH, Hsu CC, Lee WC, Chen YT, Cheng YT (2012) High-intensity diode laser in combination with bipolar transurethral resection of the prostate: a new strategy for the treatment of large prostates (>80 ml). Lasers Surg Med 44:699–704CrossRefPubMed

10.

Liu C, Zheng S, Li H, Xu K (2010) Transurethral enucleation and resection of prostate in patients with benign prostatic hyperplasia by plasma kinetics. J Urol 184:2440–2445CrossRefPubMed

11.

Carter A, Sells H, Speakman M, Ewings P, MacDonagh R, O’Boyle P (1999) A prospective randomized controlled trial of hybrid laser treatment or transurethral resection of the prostate, with a 1-year follow-up. BJU Int 83:254–259CrossRefPubMed

12.

Hauser J, Iselin CE (2012) An innovative laser for the minimally invasive treatment of benign prostatic hyperplasia. Rev Med Suisse 8:2340–2343PubMed

13.

Lee SH, Choi JI, Moon KY, Na W, Lee JB (2012) Holmium laser enucleation of the prostate: modified morcellation technique and results. Korean J Urol 53:779–784CrossRefPubMedPubMedCentral

14.

Cho SY, Park S, Jeong MY, Ro YK, Son H (2012) 120W GreenLight High Performance System laser for benign prostate hyperplasia: 68 patients with 3-year follow-up and analysis of predictors of response. Urology 80:396–401CrossRefPubMed

15.

Xia SJ (2009) Two-micron (thulium) laser resection of the prostate-tangerine technique: a new method for BPH treatment. Asian J Androl 11:277–281CrossRefPubMedPubMedCentral

16.

Bach T, Herrmann TR, Ganzer R, Burchardt M, Gross AJ (2007) RevoLix vaporesection of the prostate: initial results of 54 patients with a 1-year follow-up. World J Urol 25:257–262CrossRefPubMed

17.

Sun DC, Yang Y, Wei ZT, Hong BF, Zhang X (2010) Transurethral dividing vaporesection for the treatment of large volume benign prostatic hyperplasia using 2 micron continuous wave laser. Chin Med J 123:2370–2374PubMed

18.

Gilling PJ, Kennett K, Das AK, Thompson D, Fraundorfer MR (1998) Holmium laser enucleation of the prostate (HoLEP) combined with transurethral tissue morcellation: an update on the early clinical experience. J Endourol 12:457CrossRefPubMed

Title: Benign Prostatic Hyperplasia Treatment by Transurethral Enucleation of the Prostate Using a 2-μm Laser
Authors: He-Qing Guo
Gao-Biao Zhou
Hong-Ming Liu
Bin Sun
Guang-Xin Pan
Da-Wei Mu
Jing-Ming Yan
Ji-Zhang Xing
Di Li
Quan Hong
Publication date: 01-12-2015
Publisher: Springer India
Published in: Indian Journal of Surgery / Issue Special Issue 3/2015
Print ISSN: 0972-2068
Electronic ISSN: 0973-9793
DOI: https://doi.org/10.1007/s12262-014-1158-7

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Benign Prostatic Hyperplasia Treatment by Transurethral Enucleation of the Prostate Using a 2-μm Laser

Abstract

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Special Issue 3/2015

Neoangiogenesis. Assessment in Esophageal Adenocarcinomas

Intussusception by Villous Adenoma of the Appendix

Simple and Easy Technique for the Placement of Seprafilm During Laparoscopic Surgery

Fast Track Surgery—Minimizing Side Effects of Surgery

Breast Tuberculosis

Rural Surgery in Niger: A Multicentric Study in 21 District Hospitals